DeepMed Research

Peking University Peoples Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for Human Epidermal Growth Factor Receptor 2 (HER2) Negative Early Breast Cancer Patients

Phase 1

Recruiting

Conditions: HER2-negative Early Breast Cancer

Interventions: Drug: neoadjuvant chemotherapy upon in vitro PTC drug sensitivity screening for triple negative breast cancer
Drug: neoadjuvant chemotherapy upon in vitro PTC drug sensitivity screening for luminal like breast cancer

First Posted Date: 2021-04-08

Last Posted Date: 2022-04-06

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 46

Registration Number: NCT04836156

Locations: 🇨🇳
Peking University People's Hospital, Beijing, China

Apatinib Plus IE Chemotherapy (Ifosfamide and Etoposide) for Relapsed or Refractory Osteosarcoma

Phase 2

Suspended

Conditions: Effect of Drug
Toxicity, Drug

Interventions: Drug: apatinib

First Posted Date: 2021-04-01

Last Posted Date: 2024-05-14

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 44

Registration Number: NCT04824352

Locations: 🇨🇳
Peking University Shougang Hospital, Beijing, Beijing, China
🇨🇳
Peking University People's Hospital, Beijing, Beijing, China

Study on Classification Method of Indocyanine Green Lymphography Based on Deep Learning

Conditions: Deep Learning
Breast Cancer Related Lymphedema

Interventions: Other: No Intervention.

First Posted Date: 2021-04-01

Last Posted Date: 2021-04-01

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 200

Registration Number: NCT04824378

Locations: 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China

Comparison of Ultrasound-guided Quadratus Lumborum Block and Iliohypogastric/Ilioinguinal Nerve Block for Postoperative Pain Management in Patients Undergoing Cesarean Section

Not Applicable

Conditions: Cesarean Section
Quadratus Lumborum Block
Iliohypogastric/Ilioinguinal Nerve Block

Interventions: Procedure: iliohypogastric/ilioinguinal nerve block
Procedure: quadratus lumborum block
Procedure: epidural analgesia

First Posted Date: 2021-03-30

Last Posted Date: 2021-04-06

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 87

Registration Number: NCT04822870

Locations: 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China

Assessment of Early-detection Based on Liquid Biopsy in Lung Cancer (ASCEND-LUNG)

Recruiting

Conditions: Lung Cancer

First Posted Date: 2021-03-25

Last Posted Date: 2021-03-25

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 467

Registration Number: NCT04817046

Locations: 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China

Comparison of Sterile Gauze and Semi-permeable Film Dressing for Hemodialysis Central Venous Catheter

Not Applicable

Conditions: Infection, Bacterial

Interventions: Device: sterile gauze and tape
Device: semi-permeable film

First Posted Date: 2021-03-16

Last Posted Date: 2021-09-23

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 154

Registration Number: NCT04800575

Locations: 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China

Clinical Study on the Efficacy of Microvascular Decompression in the Treatment of Neurogenic Hypertension

Conditions: Surgery
Hypertension
Neurogenic Hypertension

Interventions: Procedure: microvascular decompression

First Posted Date: 2021-03-10

Last Posted Date: 2021-03-10

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 260

Registration Number: NCT04791410

Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for HER2 Positive Early Breast Cancer Patients

Phase 1

Recruiting

Conditions: HER2-positive Early Breast Cancer

Interventions: Drug: neoadjuvant chemotherapy upon in vitro PTC drug sensitivity screenning

First Posted Date: 2021-02-11

Last Posted Date: 2021-04-01

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 46

Registration Number: NCT04750122

Locations: 🇨🇳
Peking University People'S Hospital, Beijing, Beijing, China

The Combination of Tacrolimus and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia

Phase 2

Conditions: ITP
Immune Thrombocytopenia

Interventions: Drug: Dexamethasone
Drug: Tacrolimus

First Posted Date: 2021-02-10

Last Posted Date: 2021-02-10

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 120

Registration Number: NCT04747080

Locations: 🇨🇳
Peking University People's Hospital, Beijing, China

Efficacy and Safety of UC-MSCs for the Treatment of Steroid-resistant aGVHD Following Allo-HSCT

Phase 3

Completed

Conditions: Graft Vs Host Disease

Interventions: Drug: Anti-CD25 mAb
Drug: UC-MSC

First Posted Date: 2021-02-04

Last Posted Date: 2023-06-01

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 130

Registration Number: NCT04738981

Locations: 🇨🇳
Peking University Insititute of Hematology, Peking University People's Hospital, Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy